Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction
Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
A Phase 4 clinical trial that is open, with no blinding of subjects or randomization of
treatment. Patients with erectile problems will be given the approved drug Vitaros to treat
their condition. They will be given forms and questionnaires to complete. The information
collected will be used to assess the effectiveness, safety and the satisfaction levels with
this drug.